These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815 [TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy. Chen CC; Wang L; Lu CH; Lin JC; Jan JS J Formos Med Assoc; 2014 Dec; 113(12):949-55. PubMed ID: 24144528 [TBL] [Abstract][Full Text] [Related]
7. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials. Deng JY; Wang C; Shi XH; Jiang GL; Wang Y; Liu Y; Zhao KL Dis Esophagus; 2016 Nov; 29(8):1121-1127. PubMed ID: 26663710 [TBL] [Abstract][Full Text] [Related]
8. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Shimizuguchi T; Nihei K; Okano T; Machitori Y; Ito K; Karasawa K Int J Clin Oncol; 2017 Apr; 22(2):373-379. PubMed ID: 27778117 [TBL] [Abstract][Full Text] [Related]
9. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526 [TBL] [Abstract][Full Text] [Related]
10. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer. Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605 [TBL] [Abstract][Full Text] [Related]
11. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis. Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer. Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341 [TBL] [Abstract][Full Text] [Related]
14. Intensity modulated radiation therapy (IMRT) is not superior to three-dimensional conformal radiation (3DCRT) for adjuvant gastric radiation: A matched pair analysis. Chopra S; Agarwal A; Engineer R; Dora T; Thomas B; Sonawone S; Paul SN; Kannan S; Patil P; Mehta S; Shrivastava SK J Cancer Res Ther; 2015; 11(3):623-9. PubMed ID: 26458592 [TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Lin Y; Chen K; Lu Z; Zhao L; Tao Y; Ouyang Y; Cao X Radiat Oncol; 2018 Sep; 13(1):177. PubMed ID: 30217165 [TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference? Viani G; Hamamura AC; Faustino AC Int Braz J Urol; 2019; 45(6):1105-1112. PubMed ID: 31808397 [TBL] [Abstract][Full Text] [Related]
17. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial. Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307 [TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer. Lambrecht M; Nevens D; Nuyts S Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy. Liu GF; Bair RJ; Bair E; Liauw SL; Koshy M PLoS One; 2014; 9(1):e82642. PubMed ID: 24416146 [TBL] [Abstract][Full Text] [Related]
20. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]